First human tests begin for new drug NAV-240
NCT ID NCT06933043
Summary
This was an early-stage study to check the basic safety of a new drug called NAV-240 when given multiple times. It involved 24 healthy adults who received either the drug or a placebo (a dummy treatment). The main goal was to see what side effects might occur and to learn how the drug moves through and affects the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nucleus Network
Brisbane, Queensland, 4006, Australia
Conditions
Explore the condition pages connected to this study.